A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

NCT01389596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

295

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial Seizures

Interventions

DRUG: Pregabalin add-on therapy
DRUG: Pregabalin add-on therapy
DRUG: Pregabalin add-on therapy

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.